Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,970 | -438 | -5,775 | -4,635 | -3,695 |
| Depreciation Amortization | 1,359 | 678 | 2,740 | 2,055 | 1,346 |
| Accounts receivable | 235 | -437 | -427 | -106 | 260 |
| Accounts payable and accrued liabilities | 450 | 20 | 157 | -96 | -9 |
| Other Working Capital | 1,492 | 135 | -2,112 | -1,743 | -1,303 |
| Other Operating Activity | -566 | 461 | 743 | 574 | -42 |
| Operating Cash Flow | $1,000 | $419 | $-4,674 | $-3,951 | $-3,443 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -177 | -70 | -1,890 | -1,809 | -1,391 |
| Other Investing Activity | 0 | 0 | 0 | -115 | 0 |
| Investing Cash Flow | $-177 | $-70 | $-1,890 | $-1,924 | $-1,391 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 5,000 | 5,000 | 1,000 |
| Common Stock Issued | 418 | N/A | 19 | 0 | 0 |
| Other Financing Activity | -896 | -367 | -3,267 | -2,927 | -503 |
| Financing Cash Flow | $-478 | $-367 | $1,752 | $2,073 | $497 |
| Beginning Cash Position | 979 | 979 | 5,792 | 5,792 | 5,792 |
| End Cash Position | 1,324 | 960 | 979 | 1,990 | 1,454 |
| Net Cash Flow | $346 | $-18 | $-4,813 | $-3,802 | $-4,337 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,000 | 419 | -4,674 | -3,951 | -3,443 |
| Capital Expenditure | -181 | -70 | -1,893 | -1,811 | -1,391 |
| Free Cash Flow | 819 | 348 | -6,567 | -5,762 | -4,834 |